AUCKLAND — New Zealand’s artificial intelligence sector is experiencing explosive growth in 2026, with a wave of innovative startups and established players driving advancements in agritech, healthcare, customer experience, and maritime intelligence, positioning the country as a rising force in the global AI landscape.

From autonomous digital humans to precision farming tools and advanced analytics platforms, Kiwi AI companies are attracting international investment and talent while solving real-world problems unique to New Zealand’s economy and environment. Here are the top 10 AI companies making the biggest impact this year, based on innovation, funding, market traction and industry influence.

1. Soul Machines (Auckland/Wellington) Soul Machines remains New Zealand’s AI flagship. The company, known for creating autonomously animated “digital people” with emotional intelligence, continues to lead in humanized AI interfaces. Its technology powers customer service avatars for major banks, healthcare providers and retailers worldwide. In 2026, Soul Machines expanded its emotionally intelligent agents with improved real-time responsiveness and cultural adaptability, securing major enterprise contracts across Asia-Pacific. The company’s biologically inspired models are considered among the most advanced in conversational AI globally.

2. Halter (Auckland) Halter solidified its status as New Zealand’s first agritech unicorn with its AI-powered virtual fencing systems for cattle. Using solar-powered collars and sophisticated algorithms, Halter enables farmers to manage herds remotely, improving animal welfare and pasture utilization. The company raised significant funding in 2025 and expanded internationally in 2026. Its technology is now used on thousands of farms, demonstrating how AI can transform traditional industries like agriculture, which remains vital to New Zealand’s economy.

3. Yabble (Auckland) Yabble has emerged as a leader in insight-driven AI analytics. The platform uses generative AI to automate qualitative research and data interpretation, helping brands extract actionable insights from customer feedback at scale. In 2026, Yabble launched new features for real-time sentiment analysis and predictive trend modeling, winning major clients in retail and consumer goods. Its user-friendly interface has made advanced AI accessible to non-technical teams.

4. Thematic (Auckland) Thematic specializes in AI-powered customer experience analytics. Its platform automatically analyzes feedback from surveys, reviews, and support interactions to identify themes and trends. The company reported strong growth in 2026 as businesses increasingly prioritize customer intelligence. Thematic’s ability to turn unstructured data into strategic insights has made it a go-to solution for enterprises seeking to improve retention and satisfaction.

5. Starboard Maritime Intelligence (Auckland) Starboard leverages AI for maritime domain awareness, using satellite data and machine learning to track vessels, detect illegal fishing, and enhance maritime security. The company has gained international recognition for its work supporting Pacific Island nations and environmental monitoring. In 2026, Starboard expanded its predictive analytics capabilities, helping governments and commercial fleets optimize routes and reduce environmental impact.

6. Arcanum AI (Wellington) Arcanum AI focuses on explainable AI for regulated industries. Its platform helps organizations deploy transparent machine learning models in finance, healthcare, and government sectors. The company’s emphasis on ethics and auditability has driven adoption among institutions requiring compliance and trustworthiness. Arcanum reported strong revenue growth in 2026 as demand for responsible AI solutions increased globally.

7. Custom D (Christchurch) Custom D delivers tailored AI solutions for insurance, logistics, and manufacturing. Known for practical, industry-specific applications, the Christchurch-based firm combines machine learning with deep domain expertise. In 2026, it launched new computer vision tools for quality control and risk assessment, helping clients reduce costs and improve safety.

8. Quantiful (Auckland) Quantiful uses AI to optimize retail and e-commerce operations through demand forecasting and personalized recommendations. The company’s technology helps retailers reduce waste and improve customer experiences. Strong partnerships with major New Zealand and Australian brands have fueled steady growth throughout 2026.

9. Avertana (Auckland) Avertana applies AI to resource recovery and circular economy solutions. Its intelligent systems identify and sort materials for recycling with high accuracy. The company’s work supports New Zealand’s sustainability goals and has attracted international interest from waste management firms seeking smarter processing technologies.

10. NextWork (Auckland) NextWork focuses on AI-driven workforce upskilling and talent development. Its platform uses adaptive learning algorithms to create personalized training programs for companies undergoing digital transformation. The company raised significant funding in 2025-2026 to expand globally, capitalizing on the growing need for AI literacy in the workforce.

New Zealand’s AI Ecosystem Thrives

New Zealand’s AI sector benefits from strong government support, world-class universities (particularly the University of Auckland and University of Otago), and a collaborative startup culture. The country’s focus on ethical AI, combined with expertise in agriculture, environmental science, and healthcare, has created unique advantages in vertical AI applications.

Investment in AI startups has surged, with venture capital firms showing strong interest in companies addressing climate challenges, sustainable agriculture, and responsible technology development. Auckland remains the primary hub, but innovation is spreading to Wellington, Christchurch, and Dunedin.

Challenges remain, including talent retention (many graduates are lured overseas by higher salaries) and access to large-scale computing infrastructure. However, partnerships with international tech giants and a growing emphasis on domestic capability building are helping address these gaps.

Future Outlook

As 2026 progresses, New Zealand’s AI companies are poised for even greater impact. The combination of technical excellence, ethical focus, and practical problem-solving positions the country well in the global AI race. From Soul Machines’ empathetic digital humans to Halter’s intelligent farming systems, Kiwi innovation is proving that smaller nations can lead in specialized, high-value AI applications.

For businesses and investors looking at the AI space, New Zealand offers a compelling mix of cutting-edge technology, stable governance, and a collaborative ecosystem. The top 10 companies listed here represent only a fraction of the talent and ambition emerging from this South Pacific tech powerhouse. As the year unfolds, expect more breakthroughs from these leaders and the next wave of startups following closely behind.

A Faster Path to Care in a Digital World

In today’s healthcare system, speed and access often feel out of reach. Long wait times, insurance hurdles, and limited provider availability can slow everything down. That gap is where RX Pros found its opportunity.

“People don’t want to wait weeks just to get basic treatment,” a company representative explains. “They want something simple, fast, and reliable.”

RX Pros, also known as RX Pros, operates as a telehealth marketplace. It connects patients with licensed providers and pharmacies. The goal is not to replace healthcare providers, but to streamline how patients reach them.

From the start, the focus has been clear. Remove friction. Keep the process simple. Make care easier to access.

From Traditional Barriers to a New Model

The company’s approach reflects a broader shift in healthcare. Instead of building clinics or hiring full-time medical staff, RX Pros chose a marketplace model.

“We’re not the doctor. We’re not the pharmacy,” the team says. “We sit in the middle and make the process work better.”

This distinction matters. The platform does not provide direct medical care or dispense medication. Instead, it coordinates the steps that usually slow patients down.

The process begins with an online health questionnaire. A licensed provider reviews the case remotely. If appropriate, a prescription is issued. From there, a third-party pharmacy handles fulfillment and shipping.

“No waiting rooms. No scheduling conflicts,” they add. “Just a process that moves.”

This model allows the company to scale without the overhead of traditional healthcare systems. It also reflects how modern users expect services to work. Fast. Digital. On demand.

Why GLP-1 Weight Loss Became the Focus

While the platform supports several treatment categories, one area stands out: medical weight loss.

RX Pros has built much of its growth around GLP-1 medications, including compounded semaglutide and tirzepatide.

“We saw a huge demand for weight loss solutions that people could actually access,” the company shares. “Not everyone can afford or get approved for brand-name options.”

This gap created an opening. By focusing on compounded alternatives and telehealth delivery, the platform offers another pathway for patients seeking treatment.

But the company does not limit itself to one category. It also supports other common needs like erectile dysfunction, hair loss, and hormone therapy.

Still, weight loss remains the core driver.

“It’s where the need is highest right now,” they explain. “And where we can make the biggest impact.”

How the Online Process Actually Works

The system is designed to be simple. Each step removes a traditional barrier.

First, the patient fills out an online questionnaire. This replaces the initial office visit. Next, a licensed provider reviews the information. Depending on state rules, communication may happen through messaging, audio, or video.

“If it’s approved, the prescription moves forward right away,” they say.

From there, a compounding pharmacy prepares and ships the medication directly to the patient.

The entire process can happen without an in-person visit.

“We built this for people who don’t have time to navigate the old system,” the team explains. “Or who simply want a more private experience.”

This structure also supports users who may not have insurance coverage. The platform operates on a cash-pay model, with revenue coming from consultation fees and program subscriptions.

A Business Built Around Convenience and Speed

At its core, RX Pros is not trying to reinvent medicine. It is trying to improve access.

The company’s value proposition centers on four ideas: convenience, speed, affordability, and accessibility.

“Everything we do ties back to those four things,” they say.

Convenience comes from the fully online process. Speed comes from rapid approvals and delivery. Affordability is addressed through lower-cost alternatives. Accessibility comes from removing insurance and referral requirements.

“We’re not adding complexity,” they note. “We’re taking it away.”

This approach aligns with trends across digital health. Patients are increasingly comfortable managing care online. They expect the same ease they get from other digital services.

RX Pros is built around that expectation.

Positioning in a Growing Telehealth Market

The telehealth space has grown quickly in recent years. Many platforms now offer virtual care, but not all follow the same model.

RX Pros stands out by acting as a connector rather than a provider.

“That middle layer is where we operate,” the team says. “We bring the right pieces together.”

This positioning allows flexibility. The company can work with a network of independent providers and pharmacies. It can adapt to changes in regulations and demand without restructuring its entire operation.

It also keeps the focus on process efficiency.

“Our role is to make the system smoother,” they explain. “Not to replace the people in it.”

What Comes Next for RX Pros

Looking ahead, the company remains focused on refining its model. The demand for telehealth is not slowing down, and neither is the need for accessible treatment options.

“There’s still a lot of friction in healthcare,” they say. “We’re just getting started on removing it.”

RX Pros continues to build around its core strengths. Fast access. Digital simplicity. Scalable infrastructure.

In a space filled with complexity, the company’s approach is direct.

“Keep it simple,” they emphasize. “That’s what people actually want.”

Mumbai: Dozens of companies are going slow on plans to launch initial public offerings (IPOs), deterred by volatile investor sentiment and subsequent impact on market valuations. The calendar year started on a brisk note, with 18 mainboard IPOs collectively raising ₹18,778 crore in the March quarter, with the issues’ tally doubling from the year before, when companies raised ₹15,723 crore. The momentum has since tapered off, as the West Asia conflict sapped investor confidence. So far in April, there has been just one mainboard IPO launch, which raised ₹150 crore.

“The uncertainty in India’s IPO market is expected to remain at least for the next two to three months, depending on how the geopolitical crisis plays out,” said Prashant Singhal, partner and India markets leader at EY.

Meanwhile, the market sell-off in March and a foggy outlook prompted influential institutional investors – usually anchors of IPOs – to push back companies on valuations. “There is a mismatch in valuation expectations of issuers and investors,” said Nilesh Shah, managing director at Kotak Mutual Fund. “Issuers want the pre-war valuation. Investors want post-war valuation. As soon as east meets west, activity will pick up.”

Data from Prime Database revealed a robust IPO pipeline. As of April 17, as many as 146 companies have received Securities and Exchange Board of India (Sebi) approval to raise a total of ₹2.11 lakh crore.

Valuation Discipline
Of this, approvals of 43 companies are valid only till September. Another 84 companies are awaiting approval to collectively raise ₹1.75 lakh crore.

Valuation discipline is becoming more prominent, with greater emphasis now being placed on pricing relative to fundamentals, said Swarup Mohanty, vice chairman and chief executive at Mirae Asset Mutual Fund.
In the current scenario, prospective IPO issuers are also taking a pause to frame their offer documents on March-end audited financials, which offer a longer validity period, said investment bankers.”December audited numbers are valid only till June; hence most issuers prefer March financials in the document as they are valid till September,” said Dharmesh Mehta, MD and CEO, DAM Capital Advisors. “One should expect IPO launches starting in June, by then, hopefully, the global volatility will settle down.”

Sebi rules allow companies to go public only with up to six-month old financial data. IPO-bound firms with December quarter as the latest earnings data period in their draft red herring prospectus must launch their IPOs by June.

The market regulator earlier this month gave these companies a one-time relaxation, extending the validity of its IPO approvals in a bid to ease fundraising pressures. It said clearances expiring between April 1 and September 30 will now remain valid until September 30.

Oil prices continued to climb on Tuesday, building on the previous session’s gains as hopes of ending the U.S.-Iran war faded, while the Strait of Hormuz remained largely shut, restricting energy supplies from the key Middle East producing region to global markets.

Expectations of renewed diplomatic progress weakened over the weekend after Trump cancelled a planned Islamabad visit by his envoys Steve Witkoff and Jared Kushner. This happened even as Iranian Foreign Minister Abbas Araqchi arrived in Pakistan.

Crude oil price on April 28

Brent crude futures for June gained 45 cents, or 0.4%, to $108.68 a barrel after climbing 2.8% in the previous session to their highest close since April 7. The contract has now advanced for seven straight sessions. U.S. West Texas Intermediate (WTI) crude for June rose 58 cents, or 0.6%, to $96.96, following a 2.1% gain in the previous session.Trump’s rejection of the Iranian proposal has left the conflict at a standstill, with Iran restricting shipping through the Strait of Hormuz and the U.S. continuing its blockade of Iranian ports. The waterway normally carries supplies equal to about 20% of global oil and gas consumption.

Iran has continued to insist that vessels obtain its approval before passing through the Strait of Hormuz, while Trump said the U.S. has “total control” over the route. At the same time, the U.S. Navy has maintained its blockade targeting Iranian ports and vessels.

What’s next?

Goldman Sachs raised its fourth-quarter oil price forecasts to $90 a barrel for Brent crude and $83 for WTI, citing reduced Middle East output.“The economic risks are larger than our crude base case alone suggests because of the net upside risks to oil prices, unusually high refined product prices, products shortages risks, and the unprecedented scale of the shock,” Reuters reported, citing Goldman Sachs analysts.

According to a Haitong Futures note cited by Reuters, the current ceasefire phase increasingly appears to be preparation for further conflict. It added that if U.S.-Iran talks fail to make meaningful progress by the end of April and hostilities resume, oil prices could rise to fresh highs for the year.

Macquarie estimates crude prices may remain supported in the $85 to $90 range in the near term, with a gradual move toward $110 as supply conditions improve. It also warned that prolonged disruptions through April could push Brent as high as $150 per barrel.

Nuvama Institutional Equities said an extended closure of the Strait of Hormuz, which handles around 20 million barrels per day, could lift crude prices into the $110 to $150 range.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.